SLC6A4 has been shown to be associated with psychiatric disorders, can be used to explain the association between major depressive disorder and suicidal tendencies, and is the most promising therapeutic target for future depression research (Park et al., 2019; Hande et al., 2021). Here, SLC6A4 is linked to major depressive disorder.